Cargando…
Retracted: Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307132/ https://www.ncbi.nlm.nih.gov/pubmed/37388090 http://dx.doi.org/10.1155/2023/9817296 |
Ejemplares similares
-
Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer
por: Li, Guodong, et al.
Publicado: (2021) -
Retracted: Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)